Empagliflozin after Acute Myocardial Infarction | NEJM

SGLT2 inhibitors improve cardiovascular outcomes in high-risk patients with diabetes, chronic kidney disease, or heart failure, but their effects after acute myocardial infarction are unknown.

Research findings are summarized in a new Quick Take video.

#cardiology #clinicalmedicine #clinicaltrials #nejm

[adithyavikram]

Respected professor when usually you start Sglt2 inhibitors in your practice in a patient with acute mi, like immediately or after 24 hours or after 72 hours or during discharge, when you want to prefer the Sglt2 inhibitor professor, thank you in anticipation.

[adithyavikram]

There are many limitations in this study

[AmericanFUBAR]

I always thought SGLT 2 are overhyped.